SCOPUS 정보 검색 플랫폼

Journal of Clinical Pharmacology

Volumn 40, Issue 2, 2000, Pages 161-167

Pharmacokinetics and safety of duloxetine, a dual-serotonin and norepinephrine reuptake inhibitor

(3) Sharma, A a Goldberg, M J a Cerimele, B J a

a INDIANA UNIVERSITY (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DULOXETINE; NORADRENALIN UPTAKE INHIBITOR; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARTMENT MODEL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFECT; DRUG HALF LIFE; DRUG SAFETY; DRUG WITHDRAWAL; HEART RATE; HUMAN; HUMAN EXPERIMENT; MALE; NAUSEA; NORMAL HUMAN; QT INTERVAL; SINGLE BLIND PROCEDURE; SOMNOLENCE; STANDING; SYSTOLIC BLOOD PRESSURE; XEROSTOMIA;

EID: 0033674519 PISSN: 00912700 EISSN: None Source Type: Journal
DOI: 10.1177/00912700022008810 Document Type: Article

Times cited : (151)

References (11)

1
- 0027475388
- LY248686, a new inhibitor of serotonin and norepinephrine uptake
- (1993) Neuropsychopharmacology , vol.8 , pp. 23-33
- Wong, D.T.¹ Bymaster, F.P.² Mayle, D.A.³ Reid, L.R.⁴ Krushinski, J.H.⁵ Robertson, D.W.⁶

2
- 0030424363
- Blockade of the serotonin and norepinephrine uptake processes by duloxetine: In vitro and in vivo studies in the rat brain
- (1996) J Pharmacol Exp Ther , vol.277 , pp. 278-286
- Kasamo, K.¹ Blier, P.² De Montigny, C.³

3
- 0028935452
- Behavioral and electroencephalographic properties of duloxetine (LY248686), a reuptake inhibitor of norepinephrine and serotonin, in mice and rats
- (1995) J Pharmacol Exp Ther , vol.272 , pp. 1067-1075
- Katoh, A.¹ Eigyo, M.² Ishibashi, C.³ Naitoh, Y.⁴ Takeuchi, M.⁵ Ibii, N.⁶ Ikeda, M.⁷ Matsushita, A.⁸

4
- 0029027862
- Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthetized female cat
- (1995) J Pharmacol Exp Ther , vol.274 , pp. 1014-1024
- Thor, K.B.¹ Katofiasc, M.A.²

5
- 0018387530
- A program package for simulation and parameter estimation in pharmacokinetic systems
- (1979) Computer Programs Biomed , vol.9 , pp. 115-134
- D'Argenio, D.Z.¹ Schumitzky, A.²

6
- 0004062826
- University of Southern California
- ADAPT II Users' Guide. Los Angeles: Biomedical Simulations Resource , pp. 1992
- D'Argenio, D.Z.¹ Schumitzky, A.²

7
- 0003597577
- Cary, NC: SAS Institute
- (1989) SAS/STAT® User's Guide, version 6, 4th ed. , vol.1

8
- 85037794384
- Drug Disposition and Pharmacokinetic Report, Lilly Laboratories, Eli Lilly and Company
- (1996) 14C-LY248686 study of absorption, distribution, metabolism, and excretion in healthy human subjects
- DeLong, A.F.¹ Gillespie, T.A.² Oldham, S.W.³ Johnson, J.⁴ Patel, B.⁵ Hatcher, B.⁶ DeSante, K.⁷

9
- 0029133618
- Comparative safety and tolerability of selective serotonin reuptake inhibitors
- (1995) Human Psychopharmacology , vol.10 , pp. 185-193
- Devane, C.L.¹

10
- 0032527557
- Selective serotonin reuptake inhibitor discontinuation syndrome: A randomized clinical trial
- (1998) Biol Psychiatry , vol.44 , pp. 77-87
- Rosenbaum, J.F.¹ Sava, M.² Hoog, S.L.³ Ascroft, R.C.⁴ Krebs, W.B.⁵

11
- 0030014907
- Therapeutic options for treating major depression, and the role of venlafaxine
- (1996) Pharmacotherapy , vol.16 , Issue.3 , pp. 352-365
- Scott, M.A.¹ Shelton, P.S.² Gattis, W.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.